US Patent Issued to KETABON on Oct. 14 for "Method for treatment of depression with oral dosage forms of ketamine" (Swiss Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,440,456, issued on Oct. 14, was assigned to KETABON GMBH (Munich).

"Method for treatment of depression with oral dosage forms of ketamine" was invented by Sascha Manthei (Pratteln, Switzerland), Helene Rey (Pratteln, Switzerland), Marc Fischer (Pratteln, Switzerland) and Olaf Mundszinger (Pratteln, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to an oral dosage form for administration of ketamine and a method of preparing an oral dosage form for administration of ketamine, preferably once or twice a day."

The patent was filed on Aug. 30, 2021, under Application No. 17/460,476.

*For further information, includ...